Clearstead Trust, LLC Amgen Inc Transaction History

Clearstead Trust, LLC

$414 Million
Q4 2024

A detailed history of Clearstead Trust, LLC transactions in Amgen Inc stock. As of the latest transaction made, Clearstead Trust, LLC holds 1,094 shares of AMGN stock, worth $324,546. This represents 0.07% of its overall portfolio holdings.

Number of Shares

1,094

Previous 964 13.49%

Holding current value

$324,546

Previous $310,000 8.06%

% of portfolio

0.07%

Previous 0.08%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 10, 2025	BUY	$258.78 - $328.31 $33,641 - $42,680	130 Added 13.49%	1,094 $285,000
Q3 2024 Nov 13, 2024	SELL	$309.38 - $337.38 $309 - $337	-1 Reduced 0.1%	964 $310,000
Q2 2024 Aug 09, 2024	SELL	$262.75 - $319.31 $72,256 - $87,810	-275 Reduced 22.18%	965 $301,000
Q4 2023 Feb 06, 2024	BUY	$255.7 - $288.46 $178,990 - $201,922	700 Added 129.63%	1,240 $357,000
Q1 2023 May 10, 2023	SELL	$225.79 - $275.2 $3,161 - $3,852	-14 Reduced 2.53%	540 $130,000
Q3 2022 Nov 10, 2022	BUY	$224.46 - $253.15 $63,746 - $71,894	284 Added 105.19%	554 $125,000
Q2 2021 Aug 12, 2021	BUY	$233.58 - $259.14 $63,066 - $69,967	270 New	270 $66,000
Q1 2021 Apr 30, 2021	SELL	$221.91 - $258.6 $64,131 - $74,735	-289 Closed	0 $0
Q3 2020 Oct 23, 2020	BUY	$234.65 - $260.95 $4,458 - $4,958	19 Added 7.04%	289 $73,000
Q2 2018 Aug 20, 2018	BUY	$166.05 - $186.51 $44,833 - $50,357	270 New	270 $50,000
Q1 2018 May 15, 2018	SELL	$169.43 - $198.0 $144,015 - $168,300	-850 Closed	0 $0
Q2 2017 Aug 21, 2017	BUY	N/A	850	850 $146,000

Others Institutions Holding AMGN

# of Institutions

3,108

Shares Held

404M

Call Options Held

7.35M

Put Options Held

7.05M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $159B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearstead Trust, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clearstead Trust, LLC with notifications on news.

Account

Clearstead Trust, LLC Amgen Inc Transaction History